Eugenia Johnson
Family · Houston, TXNPI 1699368514
Payments from drug & device makers
Across 235 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$882
- GSK$537
- AstraZeneca$358
- Lilly USA, LLC$242
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$236
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,656100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,056 |
| Novo Nordisk | 40 | $882 |
| GSK | 30 | $537 |
| AstraZeneca | 12 | $358 |
| Lilly USA, LLC | 14 | $242 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $236 |
| Bayer | 7 | $170 |
| Otsuka America Pharmaceutical, Inc. | 2 | $151 |
| Amgen | 8 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $130 |
| Johnson & Johnson | 5 | $100 |
| Lundbeck LLC | 4 | $82 |
| Antares Pharma, Inc. | 4 | $75 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Exact Sciences | 3 | $57 |
| Novartis | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Pfizer | 2 | $30 |
| Halozyme Inc | 1 | $25 |
| Kaleo, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Organon | 1 | $11 |
| Genentech USA, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,656 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 14 | $349 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- David WeirDallas$959K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.